参考文献/References:
[1] GBD 2017 DALYs and HALE Collaborators. Global,regional,and national disability-adjusted life-years(DALYs) for 359 diseases and injuries and healthy life expectancy(HALE) for 195 countries and territories,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet,2018,392(10159):1859-1922.
[2] Tang D,Kang R,Berghe TV,et al. The molecular machinery of regulated cell death[J]. Cell Res,2019,29(5):347-364.
[3] Liao M,Qin R,Huang W,et al. Targeting regulated cell death(RCD) with small-molecule compounds in triple-negative breast cancer:a revisited perspective from molecular mechanisms to targeted therapies[J]. J Hematol Oncol,2022,15(1):44.
[4] Dolma S,Lessnick SL,Hahn WC,et al. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells[J]. Cancer Cell,2003,3(3):285-296.
[5] Dixon SJ,Lemberg KM,Lamprecht MR,et al. Ferroptosis:an iron-dependent form of nonapoptotic cell death[J]. Cell,2012,149(5):1060-1072.
[6] Bertrand RL. Iron accumulation,glutathione depletion,and lipid peroxidation must occur simultaneously during ferroptosis and are mutually amplifying events[J]. Med Hypotheses,2017,101:69-74.
[7] Chen X,Yu C,Kang R,et al. Iron metabolism in ferroptosis[J]. Front Cell Dev Biol,2020,8:590226.
[8] Sato H,Tamba M,Ishii T,et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins[J]. J Biol Chem,1999,274(17):11455-11458.
[9] Guo Y,Lu C,Hu K,et al. Ferroptosis in cardiovascular diseases:current status,challenges,and future perspectives[J]. Biomolecules,2022,12(3):390.
[10] Rodríguez-Graciani KM,Chapa-Dubocq XR,Ayala-Arroyo EJ,et al. Effects of ferroptosis on the metabolome in cardiac cells:the role of glutaminolysis[J]. Antioxidants(Basel),2022,11(2):278.
[11] Kobayashi M,Suhara T,Baba Y,et al. Pathological roles of iron in cardiovascular disease[J]. Curr Drug Targets,2018,19(9):1068-1076.
[12] Kim DH,Kim WD,Kim SK,et al. TGF-β1-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells[J]. Cell Death Dis,2020,11(5):406.
[13] Liu X,Zhang Y,Zhuang L,et al. NADPH debt drives redox bankruptcy:SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation[J]. Genes Dis,2021,8(6):731-745.
[14] Reed TT. Lipid peroxidation and neurodegenerative disease[J]. Free Radic Biol Med,2011,51(7):1302-1319.
[15] Kagan VE,Mao G,Qu F,et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis[J]. Nat Chem Biol,2017,13(1):81-90.
[16] Yang WS,Kim KJ,Gaschler MM,et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis[J]. Proc Natl Acad Sci U S A,2016,113(34):E4966-E4975.
[17] Tesfay L,Paul BT,Konstorum A,et al. Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death[J]. Cancer Res,2019,79(20):5355-5366.
[18] Hu H,Chen Y,Jing L,et al. The link between ferroptosis and cardiovascular diseases:a novel target for treatment[J]. Front Cardiovasc Med,2021,8:710963.
[19] Doll S,Proneth B,Tyurina YY,et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J]. Nat Chem Biol,2017,13(1):91-98.
[20] Dixon SJ,Winter GE,Musavi LS,et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death[J]. ACS Chem Biol,2015,10(7):1604-1609.
[21] Seiler A,Schneider M,F?rster H,et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death[J]. Cell Metab,2008,8(3):237-248.
[22] Chu B,Kon N,Chen D,et al. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway[J]. Nat Cell Biol,2019,21(5):579-591.
[23] Ni T,Huang X,Pan S,et al. Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy[J]. J Cell Mol Med,2021,25(21):9995-10007.
[24] Bai YT,Chang R,Wang H,et al. ENPP2 protects cardiomyocytes from erastin-induced ferroptosis[J]. Biochem Biophys Res Commun,2018,499(1):44-51.
[25] He L,Yang Y,Chen J,et al. Transcriptional activation of ENPP2 by FoxO4 protects cardiomyocytes from doxorubicin-induced toxicity[J]. Mol Med Rep,2021,24(3):668.
[26] Gao F,Zhao Y,Zhang B,et al. Suppression of lncRNA Gm47283 attenuates myocardial infarction via miR-706/Ptgs2/ferroptosis axis[J]. Bioengineered,2022,13(4):10786-10802.
[27] Li RL,Fan CH,Gong SY,et al. Effect and mechanism of LRP6 on cardiac myocyte ferroptosis in myocardial infarction[J]. Oxid Med Cell Longev,2021,2021:8963987.
[28] Liu J,Zhang M,Qin C,et al. Resveratrol attenuate myocardial injury by inhibiting ferroptosis via inducing KAT5/GPX4 in myocardial infarction[J]. Front Pharmacol,2022,13:906073.
[29] Chen HY,Xiao ZZ,Ling X,et al. ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia/reperfusion injury by regulating autophagy[J]. Mol Med,2021,27(1):14.
[30] Stamenkovic A,O’Hara KA,Nelson DC,et al. Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury[J]. Am J Physiol Heart Circ Physiol,2021,320(3):H1170-H1184.
[31] Tang LJ,Luo XJ,Tu H,et al. Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia/reperfusion[J]. Naunyn Schmiedebergs Arch Pharmacol,2021,394(2):401-410.
[32] Tang LJ,Zhou YJ,Xiong XM,et al. Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53/TfR1 pathway in the rat hearts after ischemia/reperfusion[J]. Free Radic Biol Med,2021,162:339-352.
[33] Tian H,Xiong Y,Zhang Y,et al. Activation of NRF2/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis[J]. Cell Stress Chaperones,2021,27(2):149-164.
[34] Liu B,Zhao C,Li H,et al. Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis[J]. Biochem Biophys Res Commun,2018,497(1):233-240.
[35] Fang X,Cai Z,Wang H,et al. Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis[J]. Circ Res,2020,127(4):486-501.
[36] Ma S,He LL,Zhang GR,et al. Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction[J]. Naunyn Schmiedebergs Arch Pharmacol,2022,395(8):945-962.
[37] Ito J,Omiya S,Rusu MC,et al. Iron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice[J]. Elife,2021,10:e62174.
[38] Kobiyama K,Ley K. Atherosclerosis[J]. Circ Res,2018,123(10):1118-1120.
[39] Sullivan JL. Iron in arterial plaque:modifiable risk factor for atherosclerosis[J]. Biochim Biophys Acta,2009,1790(7):718-723.
[40] Bai T,Li M,Liu Y,et al. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell[J]. Free Radic Biol Med,2020,160:92-102.
[41] Zhou Y,Zhou H,Hua L,et al. Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis[J]. Free Radic Biol Med,2021,171:55-68.
[42] Reddy KS,Prabhakaran D.Reducing the risk of cardiovascular disease:brick by BRICS[J]. Circulation,2020,141(10):800-802.
[43] Huang F,Yang R,Xiao Z,et al. Targeting ferroptosis to treat cardiovascular diseases:a new continent to be explored[J]. Front Cell Dev Biol,2021,9:737971.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(5):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(5):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(5):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
[11]邵亚兰 马继鹏 卢林鹤 熊祥 马燕燕 刘金成 杨剑.铁死亡与铁自噬在中的研究进展[J].心血管病学进展,2022,(9):787.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.005]
SHAO Yalan,MA Jipeng,LU Linhe,et al.Ferroptosis and Ferritinophagy in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2022,(5):787.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.005]